This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Source of effectiveness data
Effectiveness data were derived from a single study.
Link between effectiveness and cost data
It was not stated whether the costing was undertaken on the same patient sample as that used in the effectiveness study nor whether it was undertaken prospectively or retrospectively.
Study sample
All the patients who presented at the ED during the study period were eligible to take part in the prospective study. Residents ordered SpO2 alone, ABG, or SpO2 plus ABG measurements on their own initiative and without being given any guidelines. There is no evidence that the initial study sample was appropriate for the clinical study question. A power calculation was not used to determine the sample size. The overall number of subjects who participated in the study was 336. The intervention group included a total of 152 patients (70 men and 82 women) aged 59 (+/-23) years. The comparison group was composed of 184 consecutive patients (aged 57 (+/-23),(103 men and 81 women) who had the ABG measurement during the same period in 1992.
